Skip to content
Facebook page opens in new windowX page opens in new windowInstagram page opens in new windowYouTube page opens in new window
Jamjoom
Jamjoom Pharma
Jamjoom
  • Home
  • About us
  • Innovation
  • Products
  • Sustainability
  • Investor Relations
  • Careers
  • Contact Us
  • ุงู„ุนุฑุจูŠุฉ (Arabic)
  • Home
  • About us
  • Innovation
  • Products
  • Sustainability
  • Investor Relations
  • Careers
  • Contact Us
  • ุงู„ุนุฑุจูŠุฉ (Arabic)

Cart

You are here:
  1. Home
  2. Cart

You may be interested inโ€ฆ

Your cart is currently empty!


New in store

  • Loteprednol + Tobramycin (0.5% + 0.3%) Eye Drops
    Loteprednol + Tobramycin (0.5% + 0.3%) Eye Drops
    Read more
  • Brimo-P Optha Solution  5Ml
    Brimo-P Optha Solution 5Ml
    Read more
  • Xola Ophthalmic
    Xola Ophthalmic
    Read more
  • Tymer 5Ml
    Tymer 5Ml
    Read more

Categories

  • Careers
  • Doctors
  • JamJoom News
  • Timeline

Recent Posts

  • Iraqโ€™s Ministry of Health and Jamjoom Pharma Sign a Cooperation Protocol to launch โ€˜Ishraqaโ€™ Glaucoma Awareness Campaign
  • Lifera and Jamjoom Pharma Launch Strategic Joint Venture to Power Saudi Arabiaโ€™s Biopharma Future
  • Jamjoom Pharma Unveils New Brand Identity to Accelerate Regional and Global Growth
  • Jamjoom Pharma and Iraqi Dermatology Society Sign MoU to Transform Skin Health Awareness
  • Jamjoom Pharma Strikes Strategic Deal with Bio-Thera for securing Cosentyxยฎ Biosimilar in MENA

Recent Comments

No comments to show.
  • Contact Us
  • Careers
  • About Us
  • Products
Jamjoom
X page opens in new window Instagram page opens in new window Linkedin page opens in new window Facebook page opens in new window
Contact Us
  • 1234 Al Hamra District, Corniche Road, P.O. Box 6267 | Jeddah 21442, Saudi Arabia
  • info@jamjoompharma.com
  •   +966 (11) 322 44 56
  • Reception Ext# 3200
Quick Links
  • About us
  • Innovation
  • Sustainability
  • Investors
ยฉ 2025 Jamjoom Pharma. All rights reserved.

Medical Disclaimer | Privacy Policy

Go to Top